首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1316302

全球手術縫合線市場 - 2023-2030 年

Global Surgical Sutures Market - 2023-2030

出版日期: 2023年07月27日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球外科縫合線市場規模達到43 億美元，預計到2030 年將實現69 億美元的豐厚成長。在預測期內（2023-2030 年），全球手術縫合線市場預計將呈現6.2% 的複合年成長率。

手術縫合線是一種醫用線，用於在受傷後結紮血管和修復受損組織。可使用絲綢等天然纖維以及尼龍和聚酯等合成材料。它們具有無與倫比的拉伸強度、柔韌性、無菌性和打結安全性。

根據手術的需要，它們有各種尺寸、類型、形式和線材料可供選擇。目前有幾家生產商提供合成單絲聚二氧雜蒽酮縫合線（PDS），這種縫合線廣泛用於治療軟組織傷口和兒科心臟手術中的腹部縫合。

市場動態

手術數量的增加將推動市場成長

隨著病人手術數量的增加，醫療行業對手術縫合線的需求也在增加。隨著醫療保健行業的發展，治療方法也在不斷改進，這可能會促進市場的成長。

例如，根據NLM 的數據，全球每年約有4000 萬至5000 萬例大型手術在美國進行，2000 萬例在歐洲進行。預計其中有1-4% 的患者可能會死亡，15% 的患者會出現嚴重的術後併發症，5-15% 的患者會在30 天內再次入院。全球每年約有800 萬患者死於大手術，與心血管疾病、中風、癌症和意外事故等主要死因不相上下。

引進先進技術設備推動市場成長

人們對先進手術治療的認知不斷提高，迫使市場參與者高度重視研發工作，並向市場推出創新產品。此外，不斷湧現的新型改良自動縫合器也使全球外科醫生越來越青睞這些設備。

例如，2021 年3 月3 日，Origami Surgical 公司宣布其下一個技術平台獲得批准，該平台將為外科醫生提供更多的StitchKit 設備，以適應他們各自的機器人輔助縫合要求。在單個StitchKit 設備中，新平台可提供各種可吸收和不可吸收縫合材料。因此，上述因素有助於擴大市場。

手術縫合線的不良影響將阻礙市場成長

手術縫合會在皮膚或組織上造成穿刺傷口，從而增加感染風險。細菌可通過縫合部位進入人體，引起局部或全身感染。正確的無菌技術和術後護理是將這種風險降至最低的關鍵。

有些人可能會對縫合材料產生過敏或炎症反應。這可能會導致傷口發紅、腫脹、疼痛或延遲癒合。對於已知有過敏反應的患者，可能需要使用其他材料製成的縫合線或選擇可吸收縫合線。因此，手術縫合線的影響將阻礙市場成長。

COVID-19 影響分析

由於為防止COVID-19 的傳播，世界各地都限制了普通外科手術的手術時間，因此該流行病對外科縫合線行業產生了不利影響。此外，由於缺乏關鍵員工，世界各地多家醫院關閉了多個科室，從而減少了向非COVID-19 患者提供的手術建議數量。

此外，COVID-19 患者預計將急於投入關鍵資源進行治療。世界各地的人們因此被迫推遲選擇性治療。此外，普通外科手術的減少也對外科縫合線市場產生了負面影響。

俄烏戰爭影響分析

據估計，俄烏衝突對全球外科縫合線市場的影響不大，原因是該地區的主要市場參與者較少。不過，在預測期內，原料進出口對全球手術縫合線市場成長的影響預計不大。

Market Overview

The global surgical sutures market reached US$ 4.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 6.9 billion by 2030. The global surgical sutures market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030).

Surgical sutures are medical strands or threads that are used after an injury to ligate blood vessels and repair damaged tissues together. Natural fibres such as silk are used, as are synthetic materials like as nylon and polyester. They have tensile strength, flexibility, sterility, and knot security that are unrivalled.

Depending on the surgery, they are readily accessible in a variety of sizes, types, forms, and thread materials. Several manufacturers are currently offering synthetic monofilament polydioxanone sutures (PDS), which are widely used in the treatment of soft-tissue wounds and abdominal closures during paediatric cardiac operations.

MarketDynamics

Increase in the Number of Surgeries Will Drive the Market Growth

As the number of surgical procedures done on patients increases, so does the demand for surgical sutures in the medical industry. As a result of improvements in the healthcare business, improved treatment approaches are being created, which is likely to enhance market growth.

For instance, according to NLM, globally, every year, around 40 to 50 million major procedures are performed in the United States and 20 million in Europe. It is expected that 1-4% of these patients may die, up to 15% will experience severe postoperative morbidity, and 5-15% will be readmitted within 30 days. With an annual global mortality rate of roughly 8 million patients, major surgery is on par with the top causes of death, which include cardiovascular disease and stroke, cancer, and accident.

Introduction of Technologically Advanced Devices to Drive the Market Growth

Growing awareness of advanced surgical treatments is forcing market participants to place a high emphasis on R&D and to introduce new and innovative goods to the market. Furthermore, the increasing influx of new and improved automated sutures has resulted in a growing preference for these devices among surgeons worldwide.

For instance, March 03, 2021, Origami Surgical has announced the approval of its next technology platform, which will enable surgeons with additional StitchKit devices adapted to their individual robotic-assisted suturing requirements. Within a single StitchKit device, the new platform offers a variety of absorbable and non-absorbable suture materials. As a result, the aforementioned factors contribute to market expansion.

Adverse Effects of Surgical Sutures will Hamper the Market Growth

Surgical sutures create puncture wounds in the skin or tissues, which can increase the risk of infection. Bacteria can enter the body through the suture site and cause localized or systemic infections. Proper sterile technique and post-operative care are crucial to minimize this risk.

Some individuals may experience an allergic or inflammatory reaction to the suture material. This can lead to redness, swelling, pain, or delayed wound healing. Using sutures made from alternative materials or opting for absorbable sutures may be necessary for individuals with known sensitivities. Thus effects of surgical suture will hamper the market growth.

COVID-19 Impact Analysis

Due to restrictions put on general surgical procedure operating hours around the world to prevent the spread of COVID-19, the pandemic has had a detrimental impact on the surgical suture sector. Furthermore, the closure of multiple departments at various hospitals throughout the world due to a lack of critical staff has reduced the number of procedures advised to non-COVID-19 patients.

Furthermore, COVID-19 patients are expected to rush to commit critical resources to their care. People all across the world have been forced to postpone elective treatments as a result of this. Furthermore, fewer general surgical procedures have a negative influence on the market for surgical sutures.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global surgical sutures market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global Surgical Suturesmarket growth over the forecast period.

Segment Analysis

The global surgical sutures market is segmented based on infection product type, application, end user and region.

Orthopaedic surgery Type Segment Accounts for 28.3% of Market Share

The orthopaedic surgery segment is expected to expand and ankle and foot fractures are among the most common types of injuries treated by orthopaedic teams around the world. Suture materials used in orthopaedic surgery are used to close wounds and heal fascia, muscles, tendons, ligaments, joint capsules, and cerclage or tension band of certain fractures.

The rise of accidents will helps to drive the market growth. For instance, according to CDC, every year, 1.35 million people are killed on the world's roads. Every day, about 3,700 people are killed in automobile, bus, motorcycle, bicycle, truck, or pedestrian accidents around the world. Pedestrians, motorcyclists, and cyclists account for more than half of those fatalities.

These rising numbers of injuries mostly contribute to soft tissue injury, particularly tendons, creating a need for more orthopaedic closure procedures. As a result, the orthopaedic surgery category is predicted to increase rapidly throughout the projection period.

Geographical Analysis

Asia Pacific Accounted for Approximately 25.7% of the Market Share

Due to increased activity by leading market players in the region's countries. For instance, on January 4, 2023, MiMedx Group, Inc., a pioneer and industry leader in placental biologics, struck into an exclusive distribution deal with Gunze Medical Limited, a branch of Gunze Limited, for the sale of EPIFIX in Japan. Gunze Medical is a well-known manufacturer of bioabsorbable devices and materials, such as sutures and sheet products, used in a variety of surgical and wound care settings.

In addition to a nationwide network of over 90 sales representatives and clinical support personnel, the organisation has strong relationships with current clinicians. Thus above factors shows the growth of the region.

Competitive Landscape

The major global players in the surgical sutures market: Ethicon, Inc, Medtronic plc, B.Braun Melsungen AG, Smith& Nephew plc, Boston Scientific Corporation, Peters Surgical, DemeTECH Corporation, Internacional Farmaceutica, Sutures India, Integra Lifesciences and among others.

Why Purchase the Report?

To visualize the global surgical sutures market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of surgical sutures market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global surgical sutures market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increase in the number of accidents
  - 4.1.1.2. Introduction of technologically advanced devices
- 4.1.2. Restraints
  - 4.1.2.1. Growing demand for advanced wound closure alternatives
- 4.1.3. Opportunity
  - 4.1.3.1. Growing patient population in emerging markets
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Absorbable*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-Absorbable

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. General
8.4. Gynecological
8.5. Orthopedic
8.6. Ophthalmic
8.7. Other Surgeries

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan

Australia

10.5.6.4. Rest of Asia-Pacific

10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Ethicon, Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Medtronic plc
12.3. B.Braun Melsungen AG
12.4. Smith& Nephew plc
12.5. Boston Scientific Corporation
12.6. Peters Surgical
12.7. DemeTECH Corporation
12.8. Internacional Farmaceutica
12.9. Sutures India
12.10. Integra Lifesciences.

LIST NOT EXHAUSTIVE